about
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candi...
Read More
18.63
0.11
(0.59%)
301.1K
XNAS Volume
XNAS 12 Oct, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Apnimed Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..